Back

MicroRNA assessment in secondary mitral regurgitation - evidence for remodelling mechanisms at a cellular level

1 July 2021 (14:00 - 15:00)
Organised by:
Congress Presentation Part of: Valvular Heart Disease and Interventional Cardiology Mitral Valve Regurgitation HFA Premium Access Heart Failure 2021

About the speaker

Photo
Doctor Georg Spinka

Medical University of Vienna, Vienna (Austria)

8 More presentations in this session

Presentation thumbnail
2-year outcomes for transcatheter repair in patients with functional mitral regurgitation from the CLASP study
Doctor P. Kourkoveli (Maroussi-Athens, GR)
Abstract Slides Video
Presentation thumbnail
Impact of mitral regurgitation in patients with worsening heart failure: Insights from BIOSTAT-CHF.
Doctor M. Pagnesi (Brescia, IT)
Abstract Slides Video
Presentation thumbnail
Prevalence and determinants of right ventricular dysfunction in patients with severe symptomatic high-gradient aortic stenosis
Doctor S. Maltes (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Gender disparities in percutaneous mitral valve repair
Professor I. Oh (Pforzheim, DE)
Abstract Slides Video
Presentation thumbnail
Chronic kidney disease impact after mitraclip therapy: five-year outcomes from the GRASP registry
Doctor M. Pelliccia (Tivoli, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Valvular Heart Disease and Interventional Cardiology

The Event

Event poster

Heart Failure 2021

1 July 2021 14:00 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources